Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak(Mosaiques Diagnostics and Therapeutics (Germany)), Antonia Vlahou(Academy of Athens), William S. Hancock(Georgia Institute of Technology), Joost P. Schanstra(Inserm), Mohammed Dakna(Mosaiques Diagnostics and Therapeutics (Germany)), Danilo Fliser(Saarland University), Teresa K. Attwood(Canon (Japan)), Anna F. Dominiczak(University of Glasgow), Hassan Dihazi(Universitätsmedizin Göttingen), Timothy D. Veenstra(Leidos (United States)), Dan Theodorescu(University of Arizona), Bruce A. Julian(University of Alabama at Birmingham), Jan Novák(University of Alabama at Birmingham), Jørgen Frøkiær(Aarhus University), Giovambattista Capasso(Canon (Japan)), Walter Kölch(University College Dublin), Marc Baumann(Canon (Japan)), William B. Mattes(National Center for Toxicological Research), Goce Spasovski(Ss. Cyril and Methodius University in Skopje), Mark Girolami(University of Cambridge), Rury R. Holman(University of Oxford), Karlheinz Peter(Baker Heart and Diabetes Institute), Marta Sänchez‐Carbayo(Spanish National Cancer Research Centre), Samuel Bennett(Canon (Japan)), Marion Haubitz(Klinikum Fulda), Patricia Fernández‐Llama(Canon (Japan)), Bernard Monsarrat(Institut de Pharmacologie et de Biologie Structurale), Rolf Apweiler(European Bioinformatics Institute), Theo M. Luider(Erasmus MC), Eva M. Weissinger(Medizinische Hochschule Hannover), John P. A. Ioannidis(Innovative Research (United States)), Franck Molina(Canon (Japan)), Ziad A. Massy(Inserm), Joachim Jankowski(Charité - Universitätsmedizin Berlin), Raymond Vanholder(Ghent University Hospital), Peter Rossing(Steno Diabetes Centers), Patrick C. D’Haese(University of Antwerp), Joshua J. Coon(University of Wisconsin–Madison), Ariela Benigni(Mario Negri Institute for Pharmacological Research), Visith Thongboonkerd(Siriraj Hospital), Jon B. Klein(Canon (Japan)), Erik Bongcam‐Rudloff(Canon (Japan)), Tadashi Yamamoto(Canon (Japan)), Denis F. Hochstrasser(University of Geneva), Jérôme Garin(Inserm), Günter Allmaier(Canon (Japan)), Rainer Bischoff(Canon (Japan)), O. John Semmes(Canon (Japan)), J. H. H. Ehrich(Medizinische Hochschule Hannover)
Cited by 335
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k